2nd Quarter - Report

DENDREON PHARMACEUTICALS, LLC for DENDREON PHARMACEUTICALS, LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$48,750
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Sep 21, 2020 $48,750 Replaced
2nd Quarter - Amendment Sep 21, 2020 $48,750 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Veterans VET

Access to prostate cancer immunotherapy at the Veterans Health Administration

Foreign entity interest: Dendreon, a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.

LobbyistCovered position, as disclosed
ANDREW SAELENS —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.